Skip to main content

Table 1 The IC50 values (the drug concentrations that inhibited 50% of cell proliferation) of the compounds on MCF7 cell line

From: Synthesis, anticancer evaluation, molecular docking and ADME study of novel pyrido[4ʹ,3ʹ:3,4]pyrazolo[1,5-a]pyrimidines as potential tropomyosin receptor kinase A (TrKA) inhibitors

MCF7

20 µg/l

10 µg/l

5 µg/l

IC50/µg/l

Doxo

98.19

89.14

75.43

2.527

1

73.65

61.39

31.71

8.153

4a

84.71

74.99

35.61

6.454

4b

70.37

55.85

22.19

9.983

7a

66.12

45.66

30.13

11.17

7b

95.03

79.12

60.48

3.864

7c

92.48

69.00

40.12

6.276

7k

71.12

55.16

36.19

8.418

7l

97.26

52.28

40.19

7.227

9a

75.34

49.11

36.10

8.857

9b

72.13

51.19

33.82

9.161

9c

87.32

53.72

38.17

7.565

14a

77.19

48.62

25.14

9.963

15b

83.62

62.92

28.52

7.893

16a

77.25

57.34

55.09

4.385

16b

80.56

55.27

54.13

4.942

16c

79.61

62.79

56.81

3.805